EVICOSCREEN - EVIDENCE BASED COMPREHENSIVE PRENATAL SCREENING REPORT

Hospital ID:

Patient DOB:

City:

Patient Name:

Ethnicity:

Sample ID LI190024863

Patient ID LI190246491

Received on 11-03-2019 18:48

Registered on 11-03-2019 18:48

Reported on 12-03-2019 15:49

Dr. Kanchan Divekar

Sonography by

Referred by

To: Dandekar Clinic

Agri Samaj Mandir Road, Old Panvel

Panvel Navi Mumbai - 410206

Maharashtra

Contact: 022-27452194

Report Of: APARNA AMIT PATIL

Pt. Contact: 8454060799

Sample Type: Serum

Collection Date: 11-03-2019

Method: Electrochemiluminescence (Roche)

Lilac Insights Pvt. Ltd. 301-302, Building A-1, Rupa Solitaire Millennium Business Park, MIDC Industrial Area, Sector-1, Navi Mumbai, Maharashtra 400710.

Phone: +91 22 41841438; Website: www.lilacinsights.com; For queries or complaints, please email: info@lilacinsights.com

Veriﬁed by

Mr. Pradip Kadam

Incharge Biochemistry

Veriﬁed by

Dr. Suresh Bhanushali

MD (Path), Consultant Pathologist

Note

Test Name

AFP

Result Units

17.30 (1.3 MoM) U/mL

1. These values should not be interpreted in isolation and need to be necessarily incorporated in validated prenatal Aneuploidy risk

calculation software, along with ultrasound and biophysical parameters to calculate the patients individualised risk for aneuploidies

and interpreted accordingly. We will appreciate you providing us the outcomes.

Free ß-hCG 20.44 ng/mL

uE3 1730.00 nmol/L

Inhibin A 10.44 pg/mL

Quadruple Marker Screening

(Only Biochemical Values)

QUAD

is an evidence based prenatal screening program curated by Lilac Insights in accordance with the international guidelines

for prenatal screening to determine the probability of most common chromosomal aneuploidies in a pregnancy. It utilizes:

• Hormonal values from the pregnancy measured on Fetal Medicine foundation (UK) accredited analyzers and reagents

• Robust indigenous medians from over 5 lac+ pregnancies for different gestation ages

• Risk calculations from evidence based algorithms validated through large international studies

• External audit of the prenatal screening program by United Kingdom National External Quality Assessment Service (UKNEQAS)

scheme and Randox International Quality Assessment Scheme (RIQAS)